Groundbreaking new treatment for aggressive breast cancer has 100% survival rate
Hope is on the horizon for patients with aggressive, inherited breast cancers.
A recent clinical trial, led by researchers at Cambridge University, explored the effects of combining chemotherapy with the targeted cancer drug olaparib before surgery.
Every patient who received this protocol survived the critical three-year post-treatment period.
Advertisement
3 BRCA cancers are notoriously aggressive and difficult to treat.
Vasyl – stock.adobe.com
The research, published in Nature Communications, suggests this preemptive, two-part approach could be the most effective plan of treatment for early-stage breast cancer linked to BRCA1 and BRCA2 gene mutations.
Breast cancer or BRCA genes are present in every cell of the human body. When functioning, BRCA1 and BRCA2 repair DNA and prevent cancerous changes.
However, when a mutation compromises these genes, cancer risk increases. Inheriting this damaged DNA can increase the risk for breast and ovarian cancer in women and breast and prostate cancer in men.
Advertisement
BRCA1 or BRCA2 genes are more common in young women, and these mutations increase cancer risk by as much as 84%. Six percent of all breast cancer patients carry BRCA gene mutations, but in patients under 45, roughly 12% carry the gene.
BRCA cancers are notoriously aggressive and difficult to treat.
In 2013, Angelina Jolie, who carries the faulty BRCA1 gene, made headlines when she underwent a preventative double mastectomy. As a result of the procedure, Jolie, who lost her own mother to breast cancer, saw her chances of developing breast cancer drop from 87 percent to less than 5 percent.
Advertisement
The current protocol for treating BRCA cancers includes shrinking the tumour using chemotherapy and immunotherapy, before removing it through surgery.
3 Angelina Jolie, who carries the faulty BRCA1 gene, underwent a preventative double mastectomy.
Getty Images
The first three years after surgery — when there is the greatest risk of relapse or death — are critical.
The trial recruited patients from across the UK and aimed to test the efficacy of combining chemotherapy with olaparib before surgery and carefully timing when these treatments were administered.
Advertisement
'It is rare to have a 100% survival rate in a study like this and for these aggressive types of cancer.' Professor Jean Abraham
The study revealed that allowing a 48-hour 'gap' between chemotherapy and olaparib treatments led to more positive outcomes. Researchers believe this interval allows the patient's bone marrow to recover from chemo while leaving tumor cells receptive to olaparib.
Olaparib, sold under the brand name Lynparza, is typically taken for 12 months post-surgery. However, trial patients took the tablets pre-surgery for a period of 12 weeks.
The survival rate among the control group who received chemotherapy alone was 88%. Of these 45 patients, nine relapsed and six died within three years of surgery.
In contrast, there was a 100% survival rate among the 39 patients who received chemotherapy followed by olaparib. Of this cohort, only one patient relapsed in the three years following surgery.
'It is rare to have a 100% survival rate in a study like this and for these aggressive types of cancer,' said trial lead Professor Jean Abraham.
3 Olaparib, sold under the brand name Lynparza, is typically taken for 12 months post-surgery. However, trial patients took the tablets pre-surgery for a period of 12 weeks.
AstraZeneca Pharmaceuticals
Advertisement
'We're incredibly excited about the potential of this new approach, as it's crucial that we find a way to treat and hopefully cure patients who are diagnosed with BRCA1 and BRCA2-related cancers.'
Compared to current care protocols, the two-pronged approach of chemo and olaparib pre-surgery offers a more cost-effective and less toxic treatment for patients.
Abrahams and his team are planning the next research phase, which will aim to replicate their results in a larger study.
Advertisement
They are hopeful their findings can and will be applied to treat other cancers caused by mutated BRCA genes, including some ovarian, prostate, and pancreatic cancers.
Breast cancer is the most common cancer among US women after skin cancer. About 1 in 8 women will be diagnosed with breast cancer in their lifetime.
Though breast cancer starts in a localized part of the breast tissue, it can spread to other areas of the body, significantly decreasing rates of survival.
Survival rates among breast cancer patients whose cancer is detected before it spreads are high, between 86% and 89%. Yet if the cancer is detected after the cancer cells have migrated, that number drops to 31%.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New York Post
3 hours ago
- New York Post
Woke NYC Councilwoman Gale Brewer demanding free dental care for migrants
A lefty Upper West Side councilwoman demanded free dental care for illegal immigrants this week — as she revealed she's shelled out more than $8,000 of her own dough to keep their pearly whites intact. 'Is someone paying attention to all of their health needs!' Councilwoman Gale Brewer (D-Manhattan) roared at NYC Health Department officials during a May 23 budget hearing. 'They have a lot of health needs. Forget the dental! I'm already out $8,000-$10,000 on the dental. So who is paying attention to them?' she scolded. 7 Councilwoman Gale Brewer claims getting proper dental care for illegal immigrants is like pulling teeth. Getty Images Brewer, who earns $148,500 as a council member, told The Post Friday she's been fighting tooth and nail for migrants' health needs — including paying out of her own pocket for some of them to root canals, cavity fillings, and other dental procedures. 'I've been doing this kind of stuff for years, especially helping younger people,' said the 73-year-old Brewer, who previously fostered 35 children with her husband, author Cal Snyder. 'This is nothing new for me.' During the hearing, Brewer told Acting Health Commissioner Michelle Morse the agency needs to do a better job spreading the word about what free healthcare assistance is available to migrants at city hospitals — including dental. 'Those guys you see driving those mobile e-bikes, they all have [city-funded health insurance] …, but they don't know what to do with it, to be honest with you,' she said. 7 'They have a lot of health needs. Forget the dental! I'm already out $8,000-$10,000 on the dental. So, who is paying attention to them?' Brewer said. New York City Council 'And I assume you can't do dental, because you can't get dental for Americans — let alone for anybody else. They all have dental issues.' 'I happen to know a lot of … asylum seekers [and] support them,' she ranted. 'You can't imagine how well I know then them – extremely well. And so, I've taken on a lot of the young people, a ton of them.' 'These are young guys. They're pretty lost' about what taxpayer-funded health benefits they qualify for, Brewer added. 7 Brewer told Acting Health Commissioner Michelle Morse the agency needs to do a better job spreading the word about what free healthcare assistance is available to migrants at city hospitals. 7 Morse said her agency would work with the city's hospital system to expand education to migrants about free healthcare services through the 'NYC Care' program. New York City Council 'I'm really concerned about their health.' Critics said the longtime pol is more concerned with illegal migrants' pearly whites than the needs of her own district. 'This is another example of misplaced priorities from Gale Brewer,' said longtime Upper West Side activist Maria Danzilo. 7 Recently arrived asylum seekers get information on free health care in front of P.S. 188 in Coney Island, which has recently begun housing migrants in the school gym on May 16, 2023, in New York City. Getty Images 'It's unfortunate that Gale feels migrants' dental problems are more important that the needs of her own constituents in the community. 'What is she doing about the healthcare needs of her community? Plenty of New Yorkers also lack medical coverage.' Morse said her agency would work with the city's hospital system to expand education to migrants about free healthcare services through the 'NYC Care' program. 7 Darton College dental hygiene students Regina Schirato and Brooke Wenck give a farm worker a dental exam Wednesday evening, June 18, 2003, in a migrant farmer camp near Moultrie, Georgia. Getty Images All city hospitals – both public and private – are required by law to treat emergency patients regardless of their ability to pay or immigration status. Migrants who've applied for political asylum are also eligible for Medicaid benefits. Minors, seniors, and pregnant women are eligible for free health care regardless of their immigrant status. The Health Department declined to comment when asked if Brewer could've saved herself some cash by directing migrants with dental issues to city hospitals or health centers. 7 Brewer said she's been fighting tooth and nail for migrants' health needs. Laura Cavanaugh This isn't the first time during hearings over the next fiscal year's budget where Brewer's gone off on a wild tangent. She told Department of Correction honchos during a March hearing that the food menu offered on Rikers Island is so bad it makes her sick to her stomach. Brewer then proclaimed she wanted the city to feed jailbirds 'farm-to-table' meals, like ones served up at some of the Big Apple's top Michelin-starred restaurants.
New York Post
6 hours ago
- New York Post
Why it's time to start treating revenge as the potentially deadly addiction that it is
We don't usually think of anger and resentment the way we think about drugs or alcohol. But growing evidence suggests that, for many people, the craving for revenge follows the same patterns as substance abuse and addiction, triggering powerful biological urges that can spiral out of control and destroy lives. Recent neuroscience discoveries show that your brain on revenge looks like your brain on drugs. Real or imagined grievances (perceived mistreatment, humiliation, shame, victimization) activate the anterior insula — part of the brain's 'pain network.' In response, your brain activates its reward circuitry, causing dopamine to flood your brain, producing short-lived bursts of pleasure. 5 Legendary thinker Homer focused on themes of revenge in his iconic tale 'The Odyssey.' Getty Images For most people, this process is manageable. But for others, the self-control area — the prefrontal cortex — that's supposed to stop you from engaging in harmful behaviors gets hijacked, resulting in tragedy. We know now that revenge isn't metaphorical. It's biological. In the moment, revenge feels great. But like drugs and alcohol, the effects wear off quickly, and the pain returns. If not controlled, revenge can turn into a deadly addiction. The only way to gratify revenge cravings is by inflicting harm on the people who hurt you (or their proxies). Hard-core drug users inject narcotics into their own bodies to satisfy their cravings. Hard-core revenge users inject bullets into the bodies of others. Public health data and research show that grievance-triggered revenge cravings are the root motivation of almost all forms of violence, including youth violence and bullying, intimate partner violence, street and gang violence, police brutality, violent extremism, terrorism, and even war. 5 Almost every act of violence and warfare can be attributed to feelings of vengeance, which is why revenge must be treated as an addiction, critics believe. Getty Images Criminologists have proposed other motivations — predation, dominance, ideology, hate, and sadism. But the neuroscience of revenge suggests these are better categorized as grievances that activate revenge desires, and the hedonic reward one receives when revenge is achieved. While scientists haven't thought of revenge as an addictive process until recently, poets, playwrights, and prophets have been trying to tell us this for millennia. Writing in 700 BCE, Homer, for instance, warns of the dangers of compulsive revenge seeking in the Odyssey. The tale of Odysseus reveals the hero returning home from the Trojan War to find his wife, Penelope, in the company of more than a hundred suitors. Odysseus slaughters them all in an orgy of retaliation, unleashing a cycle of revenge that can only be stopped with the intervention of the gods. 5 Author Matthew White estimates that 445 million people have been killed in revenge-related acts of violence. Facebook In the fifth century BCE, the ancient Greek playwrights Sophocles, Aeschylus, and Euripides achieved immortal fame through tragic plays like 'Antigone,' 'Oedipus Rex,' 'Agamemnon,' and 'Medea,' which exhorted audiences about the dangers of compulsive revenge seeking. The book of Genesis cautions humanity about the risks of revenge in stories such as Cain's murder of Abel and God's vengeance-fueled mass slaughter of humanity during the flood. Today, we see the perniciousness of revenge on every scale. From vicious personal feuds and road rage to mass shootings, terrorist attacks, genocides, and war, the compulsion to seek revenge can often not be tamed, even when it costs everything. Whether it's a teenager bullied at school, a political faction nursing old grievances, or a nation seeking redress for historical wrongs, the underlying brain biology is the same. Tally the casualties of all the murders and physical and psychological assaults throughout human history, and you're likely to reach the number of dead and wounded from compulsive revenge seeking. Multicide researcher Matthew White estimates that a staggering 455 million people have been killed in just the top 100 most deadly atrocities and wars in recorded history. The World Health Organization estimates that violence-related injuries kill approximately 1.25 million people each year. 5 'The Science of Revenge' is written by James Kimmel Jr. But there's good news. Understanding violence as the result of an addictive process means that we can finally develop ways of preventing and treating it beyond mere arrest and punishment. Laws and prisons deter some people, but not those whose brains are gripped by the intense craving for payback. Like drug addicts risking death for a fix, revenge addicts risk everything for the fleeting satisfaction of retaliation. As with drug addiction, education, cognitive therapies, counseling, self-help strategies, and, potentially, anti-craving medications like naltrexone and GLP-1 drugs like Ozempic may help. But an even more powerful revenge addiction strategy exists inside our brains — forgiveness. Recent neuroscience studies show that when you simply imagine forgiving a grievance, your brain's pain, craving, and reward circuitry shut down and your self-control circuitry activates. In other words, forgiveness takes away the pain of past trauma, eliminates revenge cravings, and restores smart decision-making. 5 James Kimmel, Jr. says that forgiveness acts as 'an even more powerful revenge addiction strategy.' Michelle Senatore It's not a gift to the person who hurt you — it's a gift to yourself. You can use it as often as needed to heal yourself from the wrongs of the past, but still defend yourself from threats of the present or future. Bottom line: Forgiveness is a wonder drug that we don't use often enough. As May closes and we reach the end of Mental Health Awareness Month this year, there may be no mental illness that we need to become more aware of than revenge addiction. Unless we learn how to break the cycle of revenge, it will continue to destroy individuals, families, communities, and nations. James Kimmel, Jr., JD, is a lecturer in psychiatry at the Yale School of Medicine and author of 'The Science of Revenge: Understanding the World's Deadliest Addiction — and How to Overcome It,' from which this article is adapted.
Yahoo
16 hours ago
- Yahoo
New high-resolution structures of measles virus enzyme could lead to protective measures
May 30—Using high-resolution cryo-electron microscopy (cryoEM), researchers at The Hormel Institute, University of Minnesota, have revealed the first high-resolution renderings of the measles virus's (MeV) polymerase. This enzyme is crucial for the virus's ability to hijack cells and make copies of itself, which is one aspect that makes the virus so effective at infecting people and spreading throughout the body. For a virus that's been documented since at least the ninth century, there is still plenty we have to learn about the measles virus and how it operates, Associate Professor Bin Liu, PhD, explained as he discussed his new study published in Nature Communications. "Even well-known viruses like measles still have uncharted molecular terrain, and illuminating its structure provides valuable insights for therapeutic development," Liu said. By revealing measles' structure, Liu, along with Postdoctoral Researchers Dong Wang, PhD, and Ge Yang, PhD, have unlocked valuable insights that could help other researchers develop preventative and therapeutic measures to combat this deadly virus that can cause complications ranging from pneumonia to ear infections to encephalitis (inflammation of the brain). "Although an effective vaccine is available, recent measles outbreaks highlight the urgent need for alternative antiviral treatments," Liu said. "Because the polymerase is essential for viral genome replication, it represents a critical target for antiviral intervention." The study presents two new, distinct renderings of MeV polymerase complexes known as Lcore-P and Lfull-P-C. According to Liu, one of the most intriguing findings is the structural role of the measles virus C protein in forming the Lfull-P-C complex with two other proteins, L and P. This is surprising because the C protein was traditionally seen as a regulatory protein, not part of its core replication machinery. Now, it's shown to physically bridge and modulate the L protein's activity, potentially influencing how efficiently the virus replicates. Additionally, the study shows that the C protein widens the polymerase's RNA channel in the polymerase, possibly enhancing the processivity of RNA synthesis. That kind of physical alteration, revealed via cryoEM at near-atomic resolution, is a remarkable mechanistic insight. It suggests that the measles virus has evolved an elegant, multi-protein solution for efficient replication inside host cells. This kind of structural adaptation is a biological engineering marvel, and it highlights how even simple viruses can have complex, dynamic protein machinery. By revealing detailed interactions within the Lfull-P-C complex, the paper opens doors for next-generation antiviral drug designs that halt viral replication. "This shifts the measles conversation from 'solved by vaccines' to 'still relevant for therapeutic innovation,'" Liu concluded.
